• Dipesh Karki, Roshani Gurung, Prasanna Nepali, Hari Prasad Kaphle, Bhabuk Subedi, and Sundar Adhikari.
• Department of Medicine, Fishtail Hospital and Research Center Private Limited, Pokhara, Kaski, Nepal.
• JNMA J Nepal Med Assoc. 2022 Jul 1; 60 (251): 596599596-599.

IntroductionPatients with COVID-19 are characterised by abnormal levels of inflammatory biomarkers. Elevated D-dimer in COVID-19 patients is associated with increased mortality. This study aimed to find out the prevalence of raised D-dimer among COVID-19 patients in a tertiary care centre.MethodsThis descriptive cross-sectional study was conducted in COVID-19 unit of a tertiary care centre from 23 January 2021 to 19 June 2021. The ethical approval was taken from the Institutional Review Committee (Reference number: 077/078/159). D-dimer values and demographic data of the hospital-admitted COVID-19 patients were recorded. Convenience sampling technique was used. Point estimate and 95% Confidence Interval were calculated.ResultsOut of 180 patients with COVID-19 admitted in the hospital, the D-dimer levels were raised in 85 (47.22%) (39.93-54.51, 95% Confidence Interval) patients.ConclusionsThe prevalence of raised D-dimer among admitted COVID-19 patients was found to be lower when compared to other studies conducted in similar settings.KeywordsCOVID-19; D-dimer; Nepal; prevalence.

12 keywords...

hide…